drugset / Trial / NCT00475358
Efficacy and Safety Stress Urinary Incontinence Study
RandomizedParallel-groupDouble-blindTreatment
Summary
Study F1J-MC-SBBT will examine the effect of duloxetine treatment in women with SUI. The inclusion and exclusion criteria of this Phase 3 study will ensure that all subjects have a clinical diagnosis of SUI.
Timeline
- Start
- 2003-04
- Primary completion
- —
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 80 mg | — |